Daniel Guth, Galo Apolo, Seth A Seabury, Khristina Lung, Brian Toy, Benjamin Y Xu
{"title":"Longitudinal Trends in Resource Utilization Associated with Newly Diagnosed Primary Angle Closure Glaucoma in the United States.","authors":"Daniel Guth, Galo Apolo, Seth A Seabury, Khristina Lung, Brian Toy, Benjamin Y Xu","doi":"10.1097/IJG.0000000000002612","DOIUrl":null,"url":null,"abstract":"<p><strong>Prcis: </strong>Average cumulative two-year cost following first primary angle closure glaucoma diagnosis was $2,960. Elderly and Black patients were at higher risk of being among the costliest 5% (>$9,813) of cases, accounting for 21.3% of costs.</p><p><strong>Purpose: </strong>To assess longitudinal eye care costs associated with newly diagnosed primary angle closure glaucoma (PACG) in the United States.</p><p><strong>Methods: </strong>Patients with a diagnosis of PACG between 2009 to 2017 were identified in Optum's de-identified Clinformatics® Data Mart Database based on International Classification of Diseases (ICD) codes. Newly diagnosed PACG was defined as: 1) diagnosis by an ophthalmologist or optometrist; 2) observable for at least 12 months before and 24 months after index diagnosis; 3) no prior history of glaucoma treatment; 4) PACG-related treatment initiated after index diagnosis. Logistic regression modeling was performed to identify risk factors for being in the top 5% of cumulative two-year costs.</p><p><strong>Results: </strong>Among 12,673 eligible patients, the average cumulative two-year cost following first PACG diagnosis was $2,960. Patient costs were highest in the six months immediately following diagnosis, accounting for 52.3% of all two-year costs. 56.7% of all two-year costs were related to treatment procedures. The costliest 5% (>$9,813) of patients accounted for 21.3% of all two-year PACG-related costs. Risk factors for being in costliest 5% (P<0.05) included older age, Black race, PPO or other Medicare insurance product, living in the Midwest or the South, and recent diagnosis of anatomical narrow angles (ANA).</p><p><strong>Conclusion: </strong>Costs associated with newly diagnosed PACG were found to be disproportionately driven by a small subset of cases. Elderly and Black patients were more likely to be within the top 5% of cumulative two-year costs. Identifying and preventing the costliest PACG cases could reduce PACG-related eye care expenditures.</p>","PeriodicalId":15938,"journal":{"name":"Journal of Glaucoma","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Glaucoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IJG.0000000000002612","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Prcis: Average cumulative two-year cost following first primary angle closure glaucoma diagnosis was $2,960. Elderly and Black patients were at higher risk of being among the costliest 5% (>$9,813) of cases, accounting for 21.3% of costs.
Purpose: To assess longitudinal eye care costs associated with newly diagnosed primary angle closure glaucoma (PACG) in the United States.
Methods: Patients with a diagnosis of PACG between 2009 to 2017 were identified in Optum's de-identified Clinformatics® Data Mart Database based on International Classification of Diseases (ICD) codes. Newly diagnosed PACG was defined as: 1) diagnosis by an ophthalmologist or optometrist; 2) observable for at least 12 months before and 24 months after index diagnosis; 3) no prior history of glaucoma treatment; 4) PACG-related treatment initiated after index diagnosis. Logistic regression modeling was performed to identify risk factors for being in the top 5% of cumulative two-year costs.
Results: Among 12,673 eligible patients, the average cumulative two-year cost following first PACG diagnosis was $2,960. Patient costs were highest in the six months immediately following diagnosis, accounting for 52.3% of all two-year costs. 56.7% of all two-year costs were related to treatment procedures. The costliest 5% (>$9,813) of patients accounted for 21.3% of all two-year PACG-related costs. Risk factors for being in costliest 5% (P<0.05) included older age, Black race, PPO or other Medicare insurance product, living in the Midwest or the South, and recent diagnosis of anatomical narrow angles (ANA).
Conclusion: Costs associated with newly diagnosed PACG were found to be disproportionately driven by a small subset of cases. Elderly and Black patients were more likely to be within the top 5% of cumulative two-year costs. Identifying and preventing the costliest PACG cases could reduce PACG-related eye care expenditures.
期刊介绍:
The Journal of Glaucoma is a peer reviewed journal addressing the spectrum of issues affecting definition, diagnosis, and management of glaucoma and providing a forum for lively and stimulating discussion of clinical, scientific, and socioeconomic factors affecting care of glaucoma patients.